Female Pattern Hair Loss
| Author | Ingrid Herskovitz |
| Author | Antonella Tosti |
| Issued Date | 2013-10-01 |
| Abstract | Context:: Female pattern hair loss (FPHL) also known as female androgenetic alopecia is a common condition afflicting millions of women that can be cosmetically disrupting. Prompt diagnosis and treatment are essential for obtaining optimal outcome. Evidence Acquisition:: A) Diffuse thinning of the crown region with preservation of the frontal hairline (Ludwig’s type) Results:: The most important diseases to consider in the differential diagnosis of FPHL include Chronic Telogen Effluvium (CTE), Permanent Alopecia after Chemotherapy (PAC), Alopecia Areata Incognito (AAI) and Frontal Fibrosing Alopecia (FFA). This review describes criteria for distinguishing these conditions from FPHL. Conclusions:: The only approved treatment for FPHL, which is 2% topical Minoxidil, should be applied at the dosage of 1ml twice day for a minimum period of 12 months. This review will discuss off-label alternative modalities of treatment including 5-alfa reductase inhibitors, antiandrogens, estrogens, prostaglandin analogs, lasers, light treatments and hair transplantation. |
| DOI | https://doi.org/10.5812/ijem.9860 |
| Keyword | Polycystic Ovary Syndrome |
| Keyword | Minoxidil |
| Keyword | Female |
| Keyword | Alopecia |
| Keyword | Therapy |
| Keyword | physiopathology |
| Keyword | Androgen antagonist |
| Keyword | Therapeutic Use |
| Publisher | Brieflands |
| Title | Female Pattern Hair Loss |
| Type | Review Article |